Author Interviews, Biomarkers, Lung Cancer, Stanford / 09.03.2020
Blood Biomarker May Detect Early Stage Lung Cancer
MedicalResearch.com Interview with:
Professor Dr. Andreas Keller
Stanford University School of Medicine Office
Department of Neurology and Neurological Sciences
Chair for Clinical Bioinformatics
Saarbrücken, Germany
MedicalResearch.com: What is the background for this study?
Response: Lung cancer is among the three most common cancers and the leading cause of cancer-related deaths worldwide. The overall low survival rate of patients with lung cancer calls for improved detection tools to enable better treatment options and improved patients’ outcomes. To detect lung tumors, liquid biopsy-based strategies are increasingly explored, that are biomarkers, which are identifiable in body fluids such as human blood. The clinical application of biomarkers is, however, largely hampered by the relatively small numbers of cases that have been analyzed in the majority of the preclinical studies including the studies on lung cancer. (more…)